Orexo AB (ORX) NPV

Sell:18.34 SEKBuy:18.46 SEKPrice decreased0.12 SEK (0.65%)

Market closed |
Prices delayed by at least 15 minutes
Sell:18.34 SEK
Buy:18.46 SEK
Change:Price decreased0.12 SEK (0.65%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:18.34 SEK
Buy:18.46 SEK
Change:Price decreased0.12 SEK (0.65%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open18.72 SEK
Previous close18.60 SEK
Market capSEK 653.36m
P/E ratio-
Volume9,265
Dividend yield0.00%
EMS-

Company information

Orexo AB is a Sweden-based company active within the pharmaceutical industry. It focuses primarily on the development of new, patented drugs by combining documented substances with technologies, and the new treatments ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue37.16m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 1.30bn
Total liabilitiesSEK 812.20m
Net debt-SEK 420.90m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.